Pixee Medical develops augmented- and mixed-reality navigation platforms for orthopedic implant placement, including Knee+ for total knee replacement and Shoulder+ for total shoulder replacement. Its Knee+ system combines augmented-reality glasses and reusable instruments, has CE certification and FDA 510(k) clearance, and has been used in more than 5,000 patient procedures worldwide. Shoulder+ obtained CE mark certification in 2023 and is anticipating FDA approval by the end of the year. The company says clinical studies have validated the precision and effectiveness of its technology and positions its solutions for ambulatory surgery centers. Pixee plans to accelerate U.S. expansion with a subsidiary opening in the first quarter, deploy a new range of augmented reality navigation platforms, open an office in Singapore to expand in Asia, and hire additional talent. The company was founded in 2018 and is advancing next-generation products that incorporate immersive technologies, connectivity, and artificial intelligence. The recent capital raise will support these product and geographic expansion plans.

Total raised

$15M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2024